Macleods Pharmaceuticals
Ticker > Company >

Macleods Pharmaceuticals share price

Macleods Pharmaceuticals Ltd.

 1941   0   0

The company is currently not listed and is under IPO, so all the data might not be available.
*It is just an analytical rating of the company and not an investment advice.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year4.7%
3 Year5.84%
5 Year7.25%

Profit Growth

1 Year26.4%
3 Year-7.35%
5 Year6.65%

ROE%

1 Year23.96%
3 Year28.02%
5 Year26.56%

ROCE %

1 Year23.56%
3 Year32.95%
5 Year30.96%

Debt/Equity

0.0184

Price to Cash Flow

0

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • Company has been maintaining healthy ROE of 28.0177353344151% over the past 3 years.
  • Company has been maintaining healthy ROCE of 32.9482934234775% over the past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • The company has a high promoter holding of 100%.
  • Promoter stake has increased from 0% to 100% in the last 1 quarter.

 Limitations

  • The company has shown a poor profit growth of -7.35211309609263% for the Past 3 years.
  • The company has shown a poor revenue growth of 5.83725690520409% for the Past 3 years.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 6076.16 6590.5 7014.11 7462.67 7813.3
Total Expenditure 4736.76 4686.17 4670.54 5903.28 6381.99
Operating Profit 1339.4 1904.32 2343.56 1559.38 1431.31
Other Income 223.12 329.95 544.64 125.82 213.34
Interest 8.27 19.15 5.84 10.81 7.43
Depreciation 90.21 94.63 132.13 156.55 169.85
Exceptional Items 0 0 0 0 0
Profit Before Tax 1464.04 2120.5 2750.23 1517.84 1467.37
Tax 182.32 265.26 533.91 350.61 -8.02
Net Profit 1281.73 1855.24 2216.33 1167.23 1475.39
Adjusted EPS (Rs.) 21.4 30.98 37.01 19.49 24.64

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 19.96 19.96 19.96 59.88 59.88
Total Reserves 6257.37 8072.73 4226.69 5353.38 6840.29
Borrowings 0 31.82 0 0 0
Other N/C liabilities 213.54 223.38 -356.33 -298.23 -542.95
Current liabilities 882.89 1048.58 1428.64 1324.91 1537.23
Total Liabilities 7373.77 9396.47 5318.96 6439.94 7894.45
Assets
Net Block 1074.44 1245.48 1399.64 1473.42 1618.99
Capital WIP 51.15 213.55 252.75 334.34 189.93
Intangible WIP 0 0 0 0 0
Investments 1111.59 1168.58 16.93 234.76 438.53
Loans & Advances 32.68 33.36 123.88 89.94 89.96
Other N/C Assets 297.27 2104.22 220.6 771.75 546.2
Current Assets 4806.63 4631.28 3305.17 3535.73 5010.85
Total Assets 7373.77 9396.47 5318.96 6439.94 7894.45
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023
Profit from operations 1517.84 1467.37
Adjustment 113.05 98.35
Changes in Assets & Liabilities 95.14 664.11
Tax Paid -314.77 -228.77
Operating Cash Flow 1411.25 2001.06
Investing Cash Flow -1400.17 -2067.06
Financing Cash Flow -21.12 95.36
Net Cash Flow -10.04 29.36

Corporate Actions

Company News

 No Latest News available for this company.
Report us
Last Updated on:
Brief about Macleods Pharmaceuticals
X